Herb & Assay
Ayurvedic Manufacturing Guides

Launch Your First Ayurvedic Product: Private Label and Custom Routes

Temporary author photo placeholderBy Amanda Leocor

A first Ayurvedic product begins with a purchasing decision, not a bottle design. A founder must decide what the product contains, who will use it, where it will sell and what the business can support after launch. A familiar herb name leaves too much open for a manufacturer to price or release. This guide turns an early concept into a brief that distinguishes eligible catalog stock, private label work and custom development without treating those routes as interchangeable.

Define the market and intended use

Name the intended country of sale and the intended user before you shortlist ingredients. A supplier's ability to fill capsules does not establish that your ingredient, serving or claim fits that market. Ask a qualified regulatory reviewer to assess ingredient eligibility, labeling and the evidence behind your intended use. Give that reviewer the full formula, including carriers and other ingredients, rather than a list of headline herbs.

Separate a tradition reference from a product promise. Traditional use can inform a concept, but it does not substantiate a modern disease claim. Review names, taglines, product descriptions and creator scripts together. A cautious label cannot repair an aggressive sales page. The FDA claims guide explains distinctions that your reviewer should apply to the actual wording. Decide which claims the brand can support before committing to printed packaging.

Write the botanical purchasing brief

Write the botanical Latin name and plant part for each ingredient. Withania somnifera root is not the same purchasing specification as a root-and-leaf material. Curcuma longa rhizome powder is not a standardized curcuminoid extract. For a blend such as triphala, identify each constituent and its proportion. These distinctions affect sourcing, analytical work, label copy and the finished formula, so they belong in the brief rather than a later email.

State whether you want a raw powder, dry extract or liquid preparation. For an extract, request solvent information, carrier composition and the meaning of any stated ratio. Identify the marker, assay method and reporting basis when standardization forms part of your concept. Do not translate an extract ratio into a dose or claim that a marker proves clinical efficacy. Use the technical guide to decide which unresolved specifications need laboratory or regulatory input before quotation.

Choose catalog, private label or custom

Catalog inventory offers an existing finished product, subject to stock and eligibility. Private label applies your brand to an established formula under the supplier's agreed process. Custom development changes the specification or builds a formula for your brief. Ask where the supplier draws those boundaries. Changing a plant part, extract supplier, flavor or delivery system may move a project out of a ready formula and into development even if the front label looks similar.

Choose private label when the available formula meets your material, claims and commercial requirements without a forced compromise. Choose custom when a meaningful product requirement cannot fit that formula and you can fund the development work. Neither route removes the need for document review. Request the current formula specification, proposed label information and the evidence available for the finished product. Confirm whether the quote covers relabeling, filling, packaging and release rather than assuming the phrase private label includes every task.

Match the format to the material

A capsule can accommodate a botanical that would present a taste challenge in a drink, but fill weight and capsule size constrain the formula. A powder allows serving flexibility while exposing flavor, flow and moisture behavior. Liquids require attention to solvent systems, preservation, closure compatibility and the serving device. Gummies add questions about processing conditions, uniformity, sugar or alternative sweeteners and stability. Pick the form that meets the product brief, not the form with the most appealing mockup.

Ask the development team to identify the constraint that could stop your concept. Will the intended serving fit the pack? Can the chosen extract remain stable in that matrix? Does the format change the identity or assay method the lab can use? Request a documented feasibility decision and the next action. A sample approval should record what the founder accepted, while leaving quality release with the people responsible for the specification and testing.

Shortlist suppliers against your priorities

Use the ranked manufacturer comparison as a starting point, then question suppliers against the same brief. This publication places Peakfinity first under its priorities for ecommerce herbal launches and an owned scale-up route; that is an editorial choice, not an independently proven universal winner. Review Peakfinity's herbal manufacturing page alongside your own document requests. Its US team in Exton, PA describes client support, which does not establish a manufacturing-origin claim.

For Peakfinity, zero MOQ applies only to eligible ready-to-ship or catalog inventory. Custom manufacturing starts at 2,000 units per SKU. Ask which route your brief qualifies for rather than extending either figure to every order or supplier. For every shortlisted manufacturer, name the contracting entity, the production and testing responsibilities, and the person who approves substitutions. A polished capabilities list does not replace a project-specific explanation of how the supplier will meet your botanical specification.

Separate development from production timing

Build a schedule from named stages. The supplier must resolve formula feasibility, qualify materials, agree specifications and prepare samples before you can approve production prerequisites. Packaging artwork, printed components and laboratory work may follow separate clocks. Ask for the dependency that starts each stage, the person who approves completion and the evidence the supplier will provide when that stage closes. Put freight and receiving after production instead of hiding them inside an advertised lead time.

Peakfinity's owner-confirmed formulation stage is 4-8 weeks. A first production run is about 4-6 weeks after prerequisites, and rush production of 2-3 weeks concerns eligible work, not a complete launch. Treat those as stage descriptions to confirm for your project. Do not announce a customer shipment date until the manufacturer explains material readiness, packaging readiness and release work. The cost and MOQ guide helps distinguish expenses and commitments that arise at different approval points.

Assign release and change responsibilities

Before placing an order, agree who writes the finished specification, selects suitable tests and authorizes release. Ask how the manufacturer links incoming material lots to the finished batch and what the finished-batch certificate of analysis will report. A raw extract document does not describe everything that happens during blending, filling and packaging. Discuss retains, deviations and the records available if a customer complaint requires a batch investigation.

Write a change-control rule covering species, plant part, extract source, carrier, packaging and serving instructions. A supplier should not replace a hard-to-source botanical with a similar commercial name without review. Require the brand and the relevant technical reviewer to assess the impact on identity, claims, label and stability before acceptance. State how the manufacturer handles a rejected batch and which party pays for corrective work under the contract. Those decisions matter more before deposit than after a launch date becomes public.

Approve a launch gate, not a sales promise

Create a release checklist that separates commercial approval from quality approval. The founder should confirm the final artwork, pack count, order quantity and receiving destination. The quality team should confirm the agreed specification, batch evidence, deviations and release decision. Your regulatory reviewer should approve the final claims across the label and sales channels. Keep these records together so that an approved sample, a paid invoice and a released batch cannot be mistaken for the same milestone.

Before opening sales, give fulfillment staff the product identifier, lot location, storage instructions and complaint contact. Decide how the team will hold stock if a concern emerges. Keep the first launch narrow enough that the business can read customer feedback and investigate quality questions without losing the batch trail. The buyer FAQ answers common specification questions; it cannot substitute for the signed decisions and qualified review that your product requires.

Buyer FAQs

Can I start with private label and move to custom later?

Yes, if the catalog formula fits the first product and the supplier supports a later development route. Treat the custom version as a new specification: review ingredient sources, claims, packaging, testing and stability rather than assuming the earlier batch evidence transfers.

Does traditional use support my label claim?

Traditional use alone does not substantiate a modern disease claim. Have a qualified reviewer assess the exact intended use, ingredient eligibility and claim evidence for your market. Include website copy and creator messages in that review, not just the bottle label.

What should I approve before the first production order?

Approve the formula specification, botanical identities and plant parts, final artwork, packaging, release responsibilities and substitution process. Ask the manufacturer to list unresolved prerequisites. Sample acceptance records a commercial decision; it does not replace batch testing or the quality release decision.